| |
Year Ended
February 3, 2001
|
Year Ended
January 29, 2000
|
Year Ended
January 30, 1999
|
| (000) |
 |
| Cash Flows from Operating Activities |
|
|
|
|
|
|
| Net earnings |
$
|
151,754
|
$
|
150,106
|
$
|
133,843
|
| Adjustments to reconcile net earnings to net |
|
|
|
|
|
|
| cash
provided by operating activities: |
|
|
|
|
|
|
| Depreciation and
amortization of property and equipment |
|
44,377
|
|
38,317
|
|
33,514
|
| Other amortization |
|
10,686
|
|
9,870
|
|
9,734
|
| Deferred income
taxes |
|
10,015
|
|
(5,296)
|
|
(4,411)
|
| Change in assets and liabilities: |
|
|
|
|
|
|
| Merchandise inventory |
|
(59,071)
|
|
(34,034)
|
|
(47,635)
|
| Other current assets-net |
|
(980)
|
|
(5,979)
|
|
(4,161)
|
| Accounts payable |
|
5,751
|
|
5,867
|
|
45,735
|
| Other current liabilities-net |
|
(26,836)
|
|
21,609
|
|
31,101
|
| Other |
|
7,652
|
|
2,906
|
|
2,780
|
|
| Net cash provided
by operating activities |
|
143,348
|
|
183,366
|
|
200,500
|
|
| |
|
|
|
|
|
|
| Cash Flows from Investing Activities |
|
|
|
|
|
|
| Additions to property and equipment |
|
(82,114)
|
|
(74,012)
|
|
(78,452)
|
|
| Net cash used in
investing activities |
|
(82,114)
|
|
(74,012)
|
|
(78,452)
|
|
| |
|
|
|
|
|
|
| Cash Flows from Financing Activities |
|
|
|
|
|
|
| Borrowings under lines of credit |
|
64,000
|
|
0
|
|
0
|
| Issuance of common stock related to stock plans |
|
14,332
|
|
21,654
|
|
22,014
|
| Repurchase of common stock |
|
(169,324)
|
|
(120,000)
|
|
(109,998)
|
| Dividends paid |
|
(12,418)
|
|
(11,762)
|
|
(10,350)
|
|
| Net cash used in
financing activities |
|
(103,410)
|
|
(110,108)
|
|
(98,334)
|
|
| Net (decrease) increase in cash and cash equivalents |
|
(42,176)
|
|
(754)
|
|
23,714
|
| Cash and cash equivalents: |
|
|
|
|
|
|
| Beginning of year |
|
79,329
|
|
80,083
|
|
56,369
|
|
| End of year |
$
|
37,154
|
$
|
79,329
|
$
|
80,083
|
|
| |
|
|
|
|
|
|
| Supplemental Cash Flow Disclosures |
|
|
|
|
|
|
| Interest paid |
$
|
3,352
|
$
|
610
|
$
|
1,082
|
| Income taxes paid |
$
|
100,359
|
$
|
94,101
|
$
|
62,779
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
|
